BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao P, Qian X, Nie Y, Sun N, Wang Z, Wu J, Wei C, Ma R, Wang Z, Chai G, Li Y. Neuropeptide S Ameliorates Cognitive Impairment of APP/PS1 Transgenic Mice by Promoting Synaptic Plasticity and Reducing Aβ Deposition. Front Behav Neurosci 2019;13:138. [PMID: 31293402 DOI: 10.3389/fnbeh.2019.00138] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Markiewicz-gospodarek A, Markiewicz R, Dobrowolska B, Rahnama M, Łoza B. Relationship of Neuropeptide S (NPS) with Neurocognitive, Clinical, and Electrophysiological Parameters of Patients during Structured Rehabilitation Therapy for Schizophrenia. JCM 2022;11:5266. [DOI: 10.3390/jcm11185266] [Reference Citation Analysis]
2 Li C, Wu XJ, Li W. Neuropeptide S promotes maintenance of newly formed dendritic spines and performance improvement after motor learning in mice. Peptides 2022;156:170860. [PMID: 35970276 DOI: 10.1016/j.peptides.2022.170860] [Reference Citation Analysis]
3 Markiewicz-Gospodarek A, Markiewicz R, Dobrowolska B, Maciejewski R, Łoza B. Relationship of Neuropeptide S with Clinical and Metabolic Parameters of Patients during Rehabilitation Therapy for Schizophrenia. Brain Sci 2022;12:768. [PMID: 35741653 DOI: 10.3390/brainsci12060768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Yan QY, Lv JL, Shen XY, Ou-Yang XN, Yang JZ, Nie RF, Lu J, Huang YJ, Wang JY, Shen X. Patchouli alcohol as a selective estrogen receptor β agonist ameliorates AD-like pathology of APP/PS1 model mice. Acta Pharmacol Sin 2022. [PMID: 35091686 DOI: 10.1038/s41401-021-00857-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Shao YF, Wang C, Rao XP, Wang HD, Ren YL, Li J, Dong CY, Xie JF, Yang XW, Xu FQ, Hou YP. Neuropeptide S Attenuates the Alarm Pheromone-Evoked Defensive and Risk Assessment Behaviors Through Activation of Cognate Receptor-Expressing Neurons in the Posterior Medial Amygdala. Front Mol Neurosci 2021;14:752516. [PMID: 35002616 DOI: 10.3389/fnmol.2021.752516] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Bhat US, Shahi N, Surendran S, Babu K. Neuropeptides and Behaviors: How Small Peptides Regulate Nervous System Function and Behavioral Outputs. Front Mol Neurosci 2021;14:786471. [PMID: 34924955 DOI: 10.3389/fnmol.2021.786471] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Bicakci AO, Tsai PL, Kahl E, Mayer D, Fendt M. Dissociative Effects of Neuropeptide S Receptor Deficiency and Nasal Neuropeptide S Administration on T-Maze Discrimination and Reversal Learning. Pharmaceuticals (Basel) 2021;14:643. [PMID: 34358069 DOI: 10.3390/ph14070643] [Reference Citation Analysis]
8 Müller L, Kirschstein T, Köhling R, Kuhla A, Teipel S. Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer's Disease. J Alzheimers Dis 2021;81:855-69. [PMID: 33843674 DOI: 10.3233/JAD-201540] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
9 Kushikata T, Hirota K, Saito J, Takekawa D. Roles of Neuropeptide S in Anesthesia, Analgesia, and Sleep. Pharmaceuticals (Basel) 2021;14:483. [PMID: 34069327 DOI: 10.3390/ph14050483] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
10 Batran RZ, Gugnani KS, Maher TJ, Khedr MA. New quinolone derivatives as neuropeptide S receptor antagonists: Design, synthesis, homology modeling, dynamic simulations and modulation of Gq/Gs signaling pathways. Bioorg Chem 2021;111:104817. [PMID: 33848721 DOI: 10.1016/j.bioorg.2021.104817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhou Y, Zhu F, Liu Y, Zheng M, Wang Y, Zhang D, Anraku Y, Zou Y, Li J, Wu H, Pang X, Tao W, Shimoni O, Bush AI, Xue X, Shi B. Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy. Sci Adv 2020;6:eabc7031. [PMID: 33036977 DOI: 10.1126/sciadv.abc7031] [Cited by in Crossref: 21] [Cited by in F6Publishing: 57] [Article Influence: 10.5] [Reference Citation Analysis]
12 Abdul Manap AS, Madhavan P, Vijayabalan S, Chia A, Fukui K. Explicating anti-amyloidogenic role of curcumin and piperine via amyloid beta (Aβ) explicit pathway: recovery and reversal paradigm effects. PeerJ 2020;8:e10003. [PMID: 33062432 DOI: 10.7717/peerj.10003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Song Y, Xu W, Zhang X, Ni G. Mechanisms of Electroacupuncture on Alzheimer’s Disease: A Review of Animal Studies. Chin J Integr Med 2020;26:473-80. [DOI: 10.1007/s11655-020-3092-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
14 Neugebauer V, Mazzitelli M, Cragg B, Ji G, Navratilova E, Porreca F. Amygdala, neuropeptides, and chronic pain-related affective behaviors. Neuropharmacology 2020;170:108052. [PMID: 32188569 DOI: 10.1016/j.neuropharm.2020.108052] [Cited by in Crossref: 17] [Cited by in F6Publishing: 37] [Article Influence: 8.5] [Reference Citation Analysis]
15 Zhou F, Yan XD, Wang C, He YX, Li YY, Zhang J, Wang ZJ, Cai HY, Qi JS, Wu MN. Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic mice. Neurobiol Aging 2020;91:66-75. [PMID: 32224066 DOI: 10.1016/j.neurobiolaging.2020.02.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]